HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY RESULTS IN A DECREASE IN CD8(-CELL ACTIVATION AND PREFERENTIAL RECONSTITUTION OF THE PERIPHERAL CD4(+)T-CELL POPULATION WITH MEMORY RATHER THAN NAIVE CELLS() T)

Citation
Tg. Evans et al., HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY RESULTS IN A DECREASE IN CD8(-CELL ACTIVATION AND PREFERENTIAL RECONSTITUTION OF THE PERIPHERAL CD4(+)T-CELL POPULATION WITH MEMORY RATHER THAN NAIVE CELLS() T), Antiviral research, 39(3), 1998, pp. 163-173
Citations number
26
Categorie Soggetti
Virology,"Pharmacology & Pharmacy
Journal title
ISSN journal
01663542
Volume
39
Issue
3
Year of publication
1998
Pages
163 - 173
Database
ISI
SICI code
0166-3542(1998)39:3<163:HATRIA>2.0.ZU;2-Y
Abstract
Objective: Highly active antiretroviral therapy (HAART) can produce ma rked increases in peripheral blood CD4(+) T cells and decreases in HIV plasma RNA copy numbers. However, it is not clear whether these absol ute changes will be accompanied by a recovery in the known naive CD4() T cell depletion or a decrease in the marked CD8(+) T cell activatio n. Design: Twenty-nine patients were enrolled in studies of either nuc leoside therapy alone or nucleoside therapy combined with a protease i nhibitor (zidovudine + lamivudine + indinavir). One hundred and ninety -one examinations were carried out at three baseline time points and d uring 40 weeks of follow-up to evaluate the effect of HAART on CD4(+) memory/naive phenotype and CD8(+) T cell activation. Methods: CD4(+) a nd CD8(+) T cell number, CD62L/CD45RA expression on CD4(+) T cells and CD38 expression on CD8(+) T cells were measured by three-color flow c ytometry. Results: Most protease inhibitor treated patients had a sign ificant rise in CD4(+) numbers. The marked rise in the CD4(+) T cells seen in individuals in this study was not accompanied over a 40-week p eriod by a change ill the abnormally low CD4(+) naive compartment, and thus was almost completely of memory phenotype. The CD38 expression o n CD8(+) cells fell during treatment, and decreased to a greater degre e than the comparable rise in CD4(+) T cell counts. This decrease cont inued in many patients after the CD4(+) T cell rise or viral load decl ine had plateaued. Conclusion: HAART results in changes in activation to a greater extent than absolute changes in CD4(+) T cell numbers, bu t is not accompanied by an increase in naive CD4(+) T cells. Measureme nts of CD4(+) T cell numbers alone may not allow appropriate interpret ation of immune activation or immune competence in patients receiving those drugs. (C) 1998 Elsevier Science B.V. All rights reserved.